These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1185265)

  • 1. A new and superior adrenal scanning agent, NP-59.
    Sarkar SD; Beierwaltes H; Ice RD; Basmadjian GP; Hetzel KR; Kennedy WP; Mason MM
    J Nucl Med; 1975 Nov; 16(11):1038-42. PubMed ID: 1185265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New adrenal-scanning agent.
    Kojima M; Maeda M; Ogawa H; Nitta K; Ito T
    J Nucl Med; 1975 Jul; 16(7):666-8. PubMed ID: 1151488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 19-lodocholesterol and 6-lodomethylnorcholesterol as adrenal-scanning agents.
    Couch MW; Williams CM
    J Nucl Med; 1977 Jul; 18(7):724-7. PubMed ID: 874152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
    Sarkar SD; Cohen EL; Beierwaltes WH; Ice RD; Cooper R; Gold EN
    J Clin Endocrinol Metab; 1977 Aug; 45(2):353-62. PubMed ID: 885997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal scintigraphy with 131-I-adosterol.
    Kasperlik-Zaluska A; Chomicki OA; Hartwig W; Mikolajków A; Siwicki H
    Nuklearmedizin; 1976 Dec; 15(6):297-9. PubMed ID: 1012926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenium-75-19-selenocholesterol-a new adrenal scanning agent with high concentration in the adrenal medulla.
    Sarkar SD; Ice RD; Beierwaltes WH; Gill SP; Balachandran S; Basmadjian GP
    J Nucl Med; 1976 Mar; 17(3):212-7. PubMed ID: 1249631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of adrenal gland scanning agents, 6beta-iodomethyl-19-nor-cholest-5(10)-en-3beta-o1-131I (NCL-6-131I) and 131I-19-cholesterol (CL-19-131I)].
    Fukuchi S; Nakajima K; Miura T; Haruyama K; Kida T
    Kaku Igaku; 1976 Dec; 13(6):775-9. PubMed ID: 1035359
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of 19-iodocholesterol-131I with 6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol-131I as an adrenal-scanning agent.
    Nitta K; Ogawa H; Ito T; Kojima M; Maeda M
    Chem Pharm Bull (Tokyo); 1976 Oct; 24(10):2322-6. PubMed ID: 1017078
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with a new adrenal scanning agent, 6 beta-iodomethyl-19-nor-cholest-5(10)-en-3 beta-01-131I(NCL-6-131I, Adsterol)].
    Fukuchi S; Nakajima Y; Miura T; Haruyama K; Nakamura M
    Horumon To Rinsho; 1975 Oct; 23(10):1051-6. PubMed ID: 1238186
    [No Abstract]   [Full Text] [Related]  

  • 10. Gallbladder visualization in adrenal scanning: case report.
    Harbert JC; Canary JJ; Sandock KL
    J Nucl Med; 1976 Jan; 17(1):33-5. PubMed ID: 942579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of dopamine analogs in the adrenal medulla.
    Ice RD; Wieland DM; Beirwaltes WH; Lawton RG; Redmond MJ
    J Nucl Med; 1975 Dec; 16(12):1147-51. PubMed ID: 1194966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radioiodinated bretylium analog as a potential agent for scanning the adrenal medulla.
    Korn N; Buswink A; Yu T; Carr EA; Carroll M; Counsell RE
    J Nucl Med; 1977 Jan; 18(1):87-9. PubMed ID: 830836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 131I-19-iodocholesterol scanning of the adrenal: A new tool for the clinician.
    Skaggs RA; Winternitz WW
    J Ky Med Assoc; 1976 Jun; 74(6):290-1. PubMed ID: 932541
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenal scanning and uptake with 131I-6beta-iodomethyl-nor-cholesterol.
    Ryo UY; Johnston AS; Kim I; Pinsky SM
    Radiology; 1978 Jul; 128(1):157-61. PubMed ID: 663202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Photoscintigraphy using I 131-19-iodocholesterol in the diagnosis of adrenal gland diseases (case reports)].
    Fresco G; Bagnasco M; Fontana B; Ferrini O
    Arch Maragliano Patol Clin; 1974; 30(1):87-107. PubMed ID: 4480701
    [No Abstract]   [Full Text] [Related]  

  • 16. [New adrenal scintiscanning agents. Comparative study of 66beta-iodomethyl-19-nor-cholest-5(10)-en-3 beta-ol-125I and 19-iodocholesterol-125I].
    Umeda F; Kato K; Ibayashi H; Maeda M; Kojima M
    Kaku Igaku; 1977 Jun; 14(3):335-40. PubMed ID: 916369
    [No Abstract]   [Full Text] [Related]  

  • 17. [Scintigraphy using iodine-131-labeled 19-iodocholesterol in the study of adrenal pathology].
    Lacourcière Y; Tremblay RR; Bélanger CG; Bernier JP
    Union Med Can; 1975 Mar; 104(3):395-9. PubMed ID: 1162769
    [No Abstract]   [Full Text] [Related]  

  • 18. [Improved scintigraphic imaging of the adrenals with 6beta-131I-iodomethyl-cholesterol (author's transl)].
    Tragl KH; Angelberger P; Pils P; Wiesinger F; Kletter K
    Rofo; 1977 Oct; 127(4):365-9. PubMed ID: 144660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of large doses of 131I-19-iodocholesterol on metapyralone-induced adrenal cortical hyperplasia in dogs.
    Anderson BG; Beierwaltes WH; Nishiyama RH; Ice RD
    J Nucl Med; 1975 Oct; 16(10):928-32. PubMed ID: 170381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical and radiochemical stability of the adrenal-scanning agents, 6beta-iodomethyl-19-norcholest-5(10-en-3beta-ol and 19-iodocholest-5-en-3beta-ol.
    Scott KN; Mareci TH; Couch MW; Williams CM
    Steroids; 1977 Oct; 30(4):511-9. PubMed ID: 605458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.